Two Sigma Investments, LP Pacira Bio Sciences, Inc. Transaction History

Two Sigma Investments, LP

$42.8 Billion
Q1 2025

A detailed history of Two Sigma Investments, LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 118,344 shares of PCRX stock, worth $3.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

118,344

Previous 114,682 3.19%

Holding current value

$3.01 Million

Previous $2.16 Million 36.11%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$18.33 - $27.25 $67,124 - $99,789	3,662 Added 3.19%	118,344 $2.94 Million
Q4 2024 Feb 14, 2025	BUY	$15.3 - $20.33 $691,896 - $919,363	45,222 Added 65.11%	114,682 $2.16 Million
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $76,787 - $186,782	-6,563 Reduced 8.63%	69,460 $1.05 Million
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $859,783 - $1.06 Million	-33,717 Reduced 30.72%	76,023 $2.18 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $2.05 Million - $2.62 Million	73,829 Added 205.59%	109,740 $3.21 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $1.61 Million - $2.09 Million	-61,036 Reduced 62.96%	35,911 $1.21 Million
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $1.42 Million - $1.86 Million	-46,275 Reduced 32.31%	96,947 $2.97 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $4.26 Million - $5.6 Million	117,938 Added 466.45%	143,222 $5.74 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $898,340 - $1.1 Million	25,284 New	25,284 $1.03 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $905,915 - $1.44 Million	-17,594 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $2.99 Million - $3.82 Million	-49,886 Reduced 73.93%	17,594 $1.34 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $2.03 Million - $2.64 Million	-42,398 Reduced 38.59%	67,480 $4.06 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $14 Million - $15.7 Million	-256,353 Reduced 70.0%	109,878 $6.15 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $16.4 Million - $19.4 Million	277,883 Added 314.53%	366,231 $22.2 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $307,047 - $408,051	5,177 Added 6.22%	88,348 $6.19 Million
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $3.21 Million - $4.22 Million	-63,642 Reduced 43.35%	83,171 $4.98 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $7.63 Million - $9.25 Million	146,813 New	146,813 $8.83 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $1.22 Million - $2.08 Million	-39,675 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $2.62 Million - $4.67 Million	-92,199 Reduced 69.91%	39,675 $1.33 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $4.79 Million - $6.18 Million	131,874 New	131,874 $5.97 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $9.76 Million - $12.3 Million	-273,743 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $2.77 Million - $3.64 Million	75,818 Added 38.31%	273,743 $11.9 Million
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $3.23 Million - $3.73 Million	-88,503 Reduced 30.9%	197,925 $7.53 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $4.65 Million - $5.87 Million	112,559 Added 64.74%	286,428 $12.3 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $5.71 Million - $9.04 Million	173,869 New	173,869 $8.55 Million
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $4.86 Million - $7.51 Million	-162,121 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $3.42 Million - $5.04 Million	107,321 Added 195.84%	162,121 $7.4 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $1.96 Million - $2.16 Million	54,800	54,800 $2.06 Million

Others Institutions Holding PCRX

# of Institutions

254

Shares Held

51.1M

Call Options Held

157K

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.16B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Pacira Bio Sciences, Inc. Transaction History